Tetsuya Fujimori

Directeur/Membre du Conseil chez Cenegenics Japan KK

55 ans

Health Technology

Consumer Services

Postes actifs de Tetsuya Fujimori

Sociétés	Poste	Début	Fin
Cenegenics Japan KK Cenegenics Japan KK Medical SpecialtiesHealth Technology Cenegenics Japan KK engages in the advanced medical support business using genes, cells, and tissues. The company was founded on March 23, 2020 and is headquartered in Tokyo, Japan.	Directeur/Membre du Conseil	01/03/2020	-

Sociétés	Poste	Début	Fin
TELLA, INC.	Directeur/Membre du Conseil	25/03/2020	-
TELLA, INC.	Independent Dir/Board Member	25/03/2020	-

Osaka City University

Undergraduate Degree

Internationale

Japon

Opérationnelle

Director/Board Member	2
Independent Dir/Board Member	1
Undergraduate Degree	1

Sectorielle

Health Technology	3
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	2
tella, Inc. tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan.	Health Technology
Cenegenics Japan KK Cenegenics Japan KK Medical SpecialtiesHealth Technology Cenegenics Japan KK engages in the advanced medical support business using genes, cells, and tissues. The company was founded on March 23, 2020 and is headquartered in Tokyo, Japan.	Health Technology

Entreprise privées

Health Technology